WO2026018209 - MODIFIED CYCLODEXTRIN COMPOUNDS AND METHODS FOR THEIR USE
National phase entry is expected:
Publication Number
WO/2026/018209
Publication Date
22.01.2026
International Application No.
PCT/IB2025/057291
International Filing Date
18.07.2025
Title **
[English]
MODIFIED CYCLODEXTRIN COMPOUNDS AND METHODS FOR THEIR USE
[French]
COMPOSÉS DE CYCLODEXTRINE MODIFIÉS ET LEURS PROCÉDÉS D'UTILISATION
Applicants **
BEREN THERAPEUTICS P.B.C.
Inventors
MCMINN, Dustin
JO, Sunhwan
Priority Data
63/673,651
19.07.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 3349 | |
| EPO | Filing, Examination, Granting | 24962 | |
| Japan | Filing, Examination, Granting | 3072 | |
| South Korea | Filing, Examination, Granting | 3842 | |
| USA | Filing, Examination, Granting | 11940 |
Total:
47,165
Contact Us
Abstract[English]
Disclosed herein are modified cyclodextrin compounds (e.g., compounds of Formula I, I-a, Lal, Lb, Lbl, Lc, or Lcl) and methods of their use (e.g. methods of sequestering bilirubin by administering said compounds).[French]
L'invention concerne des composés de cyclodextrine modifiés (par exemple, des composés de formule I, I-a, Lal, Lb, Lbl, Lc ou Lcl) et des procédés d'utilisation de ceux-ci (par exemple, des procédés de séquestration de bilirubine par administration desdits composés).